Skip to content
OpenCapital
Get started

Idexx Laboratories IDXX Q4 2025 Annual earnings

Reported February 2, 2026 · Before market open

Revenue$1.1BBeat by $17.9MDiluted EPS$3.08Beat by $0.15
Revenue estimate$1.1B
EPS estimate$2.93

Next report

Aug 4, 2026 (In 3 weeks)
Revenue estimate$1.2B
EPS estimate$3.95

Financials

Q4 2025

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$658.1M+15.3%
Operating income$315.6M+20.6%
Net income$248.2M+14.8%
EPS (diluted)$3.09+17.9%

Balance sheet

See full
Cash & equivalents$180.1M-37.5%
Total debt$578.1M-21.6%
Total equity$1.6B+0.6%
Total assets$3.4B+1.7%

Cash flow

See full
Operating cash flow$355.8M+35.8%
CapEx$29.4M+0.6%
Free cash flow$326.3M+40.2%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$54.02B+59.6%
Enterprise value$54.42B+58.6%
P/E51×+12.9×
P/S12.6×+3.9×

Profitability

See full
Gross margin61.8%+0.8pp
Operating margin31.6%+2.7pp
Net margin24.6%+1.8pp
FCF margin24.6%+3.8pp

Returns & leverage

See full
Return on equity66.2%+8.5pp
Debt / equity0.4×-0.1×
Current ratio1.2×-0.1×

Segments

By product

See full
IDEXX VetLab consumables$389.0M+17.2%
Reference laboratory diagnostic and consulting services$349.2M+10.5%
Rapid assay products$76.0M-1.7%
Recurring revenue$70.6M+12.2%
CAG Diagnostics capital - instruments$58.1M+76.1%

By segment

See full
CAG$998.5M+14.7%
Water segment revenue$50.5M+11.9%
LPD$37.5M+8.5%

Versus estimates

Revenue

Q1 2026$1.1BBeat by $22.3M
Q4 2025$1.1BBeat by $17.9M
Q3 2025$1.1BBeat by $32.0MQ2 2025$1.1BBeat by $47.1MQ1 2025$998.4MBeat by $1.3MQ4 2024$954.3MBeat by $19.1M

Diluted EPS

Q1 2026$3.47Beat by $0.06
Q4 2025$3.08Beat by $0.15
Q3 2025$3.40Beat by $0.26Q2 2025$3.63Beat by $0.35Q1 2025$2.96Beat by $0.11Q4 2024$2.62Beat by $0.23

Ask the moment Idexx Laboratories reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Idexx Laboratories report Q4 2025 earnings?
Idexx Laboratories (IDXX) reported Q4 2025 earnings on February 2, 2026 before market open.
What were Idexx Laboratories's Q4 2025 revenue and EPS?
Idexx Laboratories reported revenue of $1.1B and diluted EPS of $3.08 for Q4 2025.
Did Idexx Laboratories beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.1B by $17.9M. EPS beat the consensus estimate of $2.93 by $0.15.
How did Idexx Laboratories's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 14.3% from $954.3M a year earlier and diluted EPS grew 17.6% from $2.62.
Where can I find Idexx Laboratories's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-008904) and the 10-K periodic report (0000874716-26-000038) directly on SEC EDGAR. The filing index links above go to sec.gov.